Wednesday, October 29, 2014

Health Care

Market Watch | Insider-trading probe focuses on Medicare agency
The day Medicare officials began discussing whether to set new coverage limits on a costly new prostate-cancer treatment, the official in charge emailed three colleagues to put a “close hold” on the process. That meant: Keep quiet until an announcement later that month.